Kmish
Known for
Semaglutide App for GLP-1
Snapshot
Rivals analysis in progress
Portfolio
Free 11
app
Medical1
Last updated
Semaglutide App for GLP-1
v1.1.9
8mo ago
Publisher DNA
What defines Kmish?
AI intelligence is not yet available for Kmish. The portfolio data below is up to date.
Portfolio
What does Kmish ship?
Apps
1 app analysed
Protein-focused tracking addresses specific side-effect concerns like muscle mass loss
- The simple interface for tracking protein and water intake helps users manage their health goals effectively
- Data loss and inability to view historical logs prevent users from tracking their long-term progress
Single-market publisher, every app ships only to United States.
Based on 1 of 1 app with localized market data · last scanned .
Americas (1)
- United States1 / 1
Core markets (1/1 apps)
United States
User Sentiment
How do users feel about their apps?
1
Positive apps
0
Neutral / mixed
0
Negative apps
65/100
Avg sentiment score
Frequently asked questions
How many apps does Kmish publish?
Kmish has 1 app tracked by Marlvel, primarily in the Medical category.
What kind of apps does Kmish make?
Kmish's portfolio is concentrated in Medical, with an average rating of 4.7/5 across rated apps.
What is Kmish's top app?
By review volume across the portfolio, Semaglutide App for GLP-1 is Kmish's best-known app tracked by Marlvel.
In how many countries are Kmish's apps available?
Marlvel has tracked Kmish's apps across 1 country.